載入...
Testosterone, HDL and cardiovascular risk in men: the jury is still out
“Even when reductions in HDL-cholesterol are observed as a consequence of androgen therapy, the implications for cardiovascular risk modification remain highly uncertain.”
Na minha lista:
| 發表在: | Clin Lipidol |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2012
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4219622/ https://ncbi.nlm.nih.gov/pubmed/25379057 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/clp.12.38 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|